Oxford University's push for Covid-19 vaccine may stumble due to drop in infections
26th May 2020 11:53
(Sharecast News) - Oxford University's attempts to develop a vaccine against the novel coronavirus could run into an apparently unexpected hurdle, the head of its research team said.
Read moreNovavax begins trialling Covid-19 vaccine in Australia
26th May 2020 11:11
(Sharecast News) - Biotechnology firm Novavax has begun trialling a Covid-19 vaccine candidate in Australia as it hopes to release a proven vaccine by the end of 2020.
Read moreGlaxoSmithKline hails HIV treatment breakthrough
18th May 2020 07:40
(Sharecast News) - GlaxoSmithKline said on Monday that ViiV Healthcare, in which it owns a majority stake, is ending a study early after finding that its long-acting injectable formulation of cabotegravir dosed every two months shows higher efficacy than daily oral pre-exposure prophylaxis (PrEP) in preventing HIV transmission.
Read moreGlaxoSmithKline divests of holding in Hindustan Unilever
7th May 2020 09:28
(Sharecast News) - GlaxoSmithKline announced a rise in the proceeds it was expecting from the sale of its Indian consumer healthcare portfolio on Thursday, as it sold its holding in Hindustan Unilever.
Read moreTuesday broker round-up
5th May 2020 13:27
(Sharecast News) - Stagecoach Group: Canaccord upgrades to buy with a target price of 110p.
Read moreMonday broker round-up
4th May 2020 13:34
(Sharecast News) - Go-Ahead Group: Canaccord upgrades to buy with a target price of 1,650p.
Read moreGlaxoSmithKline gets FDA nod for latest 'Zejula' application
30th Apr 2020 07:37
(Sharecast News) - GlaxoSmithKline announced on Thursday that the US Food and Drug Administration (FDA) approved the company's supplemental New Drug Application (sNDA) for 'Zejula', or niraparib.
Read moreGlaxoSmithKline Q1 sales jump; full-year guidance reaffirmed
29th Apr 2020 12:13
(Sharecast News) - GlaxoSmithKline backed its full-year guidance on Wednesday as it posted a jump in first-quarter turnover, with growth across all three of its business and as sales of shingles vaccine Shingrix surged.
Read moreThursday broker round-up
23rd Apr 2020 14:04
(Sharecast News) - Hargreaves Lansdown: Deutsche Bank downgrades to sell with a target price of 1,325p.
Read moreAlmost a third of FTSE 100 cut or scrap dividends
15th Apr 2020 12:01
(Sharecast News) - Almost one-third of FTSE 100 companies have cut or scrapped their dividends during the coronavirus crisis, leaving investors relying on 10 companies for two-thirds of the index's likely payouts in 2020, research shows.
Read moreGSK and Sanofi aim for Covid-19 vaccine in 2021
14th Apr 2020 12:08
(Sharecast News) - GlaxoSmithKline said it was working with Sanofi of France on a Covid-19 vaccine that could be ready by the second half of 2021.
Read moreGSK joins up with Vir Biotech on coronavirus treatments
6th Apr 2020 13:19
(Sharecast News) - GlaxoSmithKline and Vir Biotechnology of the US have joined forces to research treatments for the virus behind the Covid-19 crisis and other coronaviruses.
Read moreUK cough and cold medicine prices rise 10.7%
2nd Apr 2020 14:42
(Sharecast News) - The price of cough and cold medicine rose by 10.7% last week as retailers take advantage of the rise in demand due to the coronavirus outbreak.
Read moreTuesday broker round-up
17th Mar 2020 13:00
(Sharecast News) - Ti Fluid Systems: Citigroup downgrades to neutral with a target price of 140p.
Read moreTuesday broker round-up
3rd Mar 2020 12:46
(Sharecast News) - Huntsworth: Liberum downgrades to hold with a target price of 108p.
Read more